The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene

Cancer Res. 1996 Feb 15;56(4):728-32.

Abstract

Very little is known about the molecular and genetic mechanisms involved in prostate cancer. Previous studies have shown frequent loss of heterozygosity (40%) at chromosomal regions 8p, 10q, and 16q, suggesting the presence of tumor suppressor genes in these regions. The LNCaP cell line, established from a metastatic lesion of human prostatic adenocarcinoma, carries a t(6;16)(p21;q22) translocation. To determine whether this translocation involved genes important in the process of malignant transformation, we cloned and sequenced the t(6;16) breakpoint of this cell line. Sequence analysis showed that the breakpoint is within the haptoglobin gene cluster on chromosome 16, and that, on chromosome 6, the break occurs within a novel gene, tpc, similar to the prokaryotic S10 ribosomal protein gene. The translocation results in the production of a fusion transcript, tpc/hpr.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Neoplasm*
  • Base Sequence
  • Biomarkers, Tumor
  • Blood Proteins / biosynthesis
  • Blood Proteins / genetics*
  • Cell Line
  • Chromosome Deletion
  • Chromosome Mapping
  • Chromosomes, Human, Pair 16*
  • Chromosomes, Human, Pair 6*
  • Cloning, Molecular
  • DNA Probes
  • Gene Rearrangement
  • Genes, Tumor Suppressor
  • Haptoglobins / biosynthesis
  • Haptoglobins / genetics*
  • Humans
  • Hybrid Cells
  • Male
  • Mice
  • Molecular Sequence Data
  • Prostatic Neoplasms / genetics*
  • Recombinant Fusion Proteins / biosynthesis
  • Transcription, Genetic
  • Translocation, Genetic*
  • Tumor Cells, Cultured

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Blood Proteins
  • DNA Probes
  • HPR protein, human
  • Haptoglobins
  • Recombinant Fusion Proteins